Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Brand
Brand / product

Canlos

Canagliflozin · 300 mg

ShareSend this page
Official DRAP price PKR 1,465.98 14's
PKR 104.71 / tablet
✓ DRAP listed · Verified 2026-08-08
Unit-price intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unit
Lowest unit pricePKR 100.47/ tablet
Highest unit pricePKR 107.19/ tablet
Unit-price rangePKR 100.47–107.19/ tablet
Comparable alternatives5current-price listings
This brandPKR 104.71 / tablet
4.2% above lowest unit price
Low
High
Compare equivalent brands 6 comparable presentations
BrandCompanyPackOfficial pack priceUnit price
Canlos PHARMEVO (PVT) LTD. 30's PKR 3,014.05 PKR 100.47/ tablet
Nizocan Bio-Labs(Pvt) Ltd 30's PKR 3,085.40 PKR 102.85/ tablet
Canlos PHARMEVO (PVT) LTD. 10's PKR 1,046.71 PKR 104.67/ tablet
Canlos This brand PHARMEVO (PVT) LTD. 14's PKR 1,465.98 PKR 104.71/ tablet
Nizocan Bio-Labs(Pvt) Ltd 10's PKR 1,071.48 PKR 107.15/ tablet
Nizocan Bio-Labs(Pvt) Ltd 14's PKR 1,500.68 PKR 107.19/ tablet

Comparison is calculated from current listed prices and normalized pack quantities. Products with a different strength, dosage form, or incompatible/ambiguous pack unit are excluded.

Product details

Generic
Canagliflozin
Therapeutic area
Endocrine & metabolic
Drug class
Antidiabetic medicines
ATC
Strength
300 mg
Dosage form
Tablet
Pack
14's
Registration no.
105266
Verification
2026-08-08

Manufacturer

PHARMEVO (PVT) LTD.

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 1,465.982025-08-042026-08-08DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Price note: Unit-price comparisons are informational calculations from source-listed pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.